目次

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by End-user
Market segments
Comparison by End-user
Diagnostic centers - Market size and forecast 2020-2025
Hospitals and clinics - Market size and forecast 2020-2025
Market opportunity by End-user

Market Segmentation by Type
Market segments
Comparison by Type
HIV rapid immunoassay test - Market size and forecast 2020-2025
HIV rapid molecular diagnostic test - Market size and forecast 2020-2025
Market opportunity by Type

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity By Geographical Landscape
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Abbott Laboratories
Becton Dickinson and Co.
Bio Rad Laboratories Inc.
bioMerieux SA
Danaher Corp.
F. Hoffmann-La Roche Ltd.
Hologic Inc.
Nectar Lifesciences Ltd.
QIAGEN NV
Trinity Biotech Plc

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Key Finding 9
9: Parent market
10: Market characteristics
11: Offerings of vendors included in the market definition
12: Market segments
13: Global - Market size and forecast 2020 - 2025 ($ million)
14: Global market: Year-over-year growth 2020 - 2025 (%)
15: Five forces analysis 2020 & 2025
16: Bargaining power of buyers
17: Bargaining power of suppliers
18: Threat of new entrants
19: Threat of substitutes
20: Threat of rivalry
21: Market condition - Five forces 2020
22: End-user - Market share 2020-2025 (%)
23: Comparison by End-user
24: Diagnostic centers - Market size and forecast 2020-2025 ($ million)
25: Diagnostic centers - Year-over-year growth 2020-2025 (%)
26: Hospitals and clinics - Market size and forecast 2020-2025 ($ million)
27: Hospitals and clinics - Year-over-year growth 2020-2025 (%)
28: Market opportunity by End-user
29: Type - Market share 2020-2025 (%)
30: Comparison by Type
31: HIV rapid immunoassay test - Market size and forecast 2020-2025 ($ million)
32: HIV rapid immunoassay test - Year-over-year growth 2020-2025 (%)
33: HIV rapid molecular diagnostic test - Market size and forecast 2020-2025 ($ million)
34: HIV rapid molecular diagnostic test - Year-over-year growth 2020-2025 (%)
35: Market opportunity by Type
36: Customer landscape
37: Market share By Geographical Landscape 2020-2025 (%)
38: Geographic comparison
39: North America - Market size and forecast 2020-2025 ($ million)
40: North America - Year-over-year growth 2020-2025 (%)
41: Europe - Market size and forecast 2020-2025 ($ million)
42: Europe - Year-over-year growth 2020-2025 (%)
43: Asia - Market size and forecast 2020-2025 ($ million)
44: Asia - Year-over-year growth 2020-2025 (%)
45: ROW - Market size and forecast 2020-2025 ($ million)
46: ROW - Year-over-year growth 2020-2025 (%)
47: Key leading countries
48: Market opportunity By Geographical Landscape ($ million)
49: Impact of drivers and challenges
50: Vendor landscape
51: Landscape disruption
52: Industry risks
53: Vendors covered
54: Market positioning of vendors
55: Abbott Laboratories - Overview
56: Abbott Laboratories - Business segments
57: Abbott Laboratories - Key offerings
58: Abbott Laboratories - Key customers
59: Abbott Laboratories - Segment focus
60: Becton Dickinson and Co. - Overview
61: Becton Dickinson and Co. - Business segments
62: Becton Dickinson and Co. - Key offerings
63: Becton Dickinson and Co. - Key customers
64: Becton Dickinson and Co. - Segment focus
65: Bio Rad Laboratories Inc. - Overview
66: Bio Rad Laboratories Inc. - Business segments
67: Bio Rad Laboratories Inc. - Key offerings
68: Bio Rad Laboratories Inc. - Key customers
69: Bio Rad Laboratories Inc. - Segment focus
70: bioMerieux SA - Overview
71: bioMerieux SA - Business segments
72: bioMerieux SA - Key offerings
73: bioMerieux SA - Key customers
74: bioMerieux SA - Segment focus
75: Danaher Corp. - Overview
76: Danaher Corp. - Business segments
77: Danaher Corp. - Key offerings
78: Danaher Corp. - Key customers
79: Danaher Corp. - Segment focus
80: F. Hoffmann-La Roche Ltd. - Overview
81: F. Hoffmann-La Roche Ltd. - Business segments
82: F. Hoffmann-La Roche Ltd. - Key offerings
83: F. Hoffmann-La Roche Ltd. - Key customers
84: F. Hoffmann-La Roche Ltd. - Segment focus
85: Hologic Inc. - Overview
86: Hologic Inc. - Business segments
87: Hologic Inc. - Key offerings
88: Hologic Inc. - Key customers
89: Hologic Inc. - Segment focus
90: Nectar Lifesciences Ltd. - Overview
91: Nectar Lifesciences Ltd. - Business segments
92: Nectar Lifesciences Ltd. - Key offerings
93: Nectar Lifesciences Ltd. - Key customers
94: Nectar Lifesciences Ltd. - Segment focus
95: QIAGEN NV - Overview
96: QIAGEN NV - Business segments
97: QIAGEN NV - Key offerings
98: QIAGEN NV - Key customers
99: QIAGEN NV - Segment focus
100: Trinity Biotech Plc - Overview
101: Trinity Biotech Plc - Product and service
102: Trinity Biotech Plc - Key offerings
103: Trinity Biotech Plc - Key customers
104: Trinity Biotech Plc - Segment focus
105: Currency conversion rates for US$
106: Research Methodology
107: Validation techniques employed for market sizing
108: Information sources
109: List of abbreviations